Valuation: Carvolix

Market Cap 366M 328M 303M 275M 513M 34.84B 520M 3.63B 1.45B 18.23B 1.37B 1.34B 57.88B P/E 2026 *
-12.1x
P/E 2027 * -12.1x
Enterprise Value 401M 360M 332M 301M 563M 38.18B 569M 3.98B 1.58B 19.98B 1.5B 1.47B 63.42B EV / Sales 2026 *
280x
EV / Sales 2027 * 11.6x
Free-Float
16.12%
Yield 2026 *
-
Yield 2027 * -
1 day+0.36%
1 week-6.42%
Current month-4.15%
1 month+0.36%
6 months+93.71%
Current year+220.23%
1 week 5.36
Extreme 5.36
6.08
1 month 4.92
Extreme 4.92
6.08
Current year 1.73
Extreme 1.73
7.56
1 year 1.33
Extreme 1.33
7.56
3 years 1.16
Extreme 1.16
7.56
5 years 0.93
Extreme 0.93
7.56
10 years 0.93
Extreme 0.93
8.6
Date Insider Type Main position Quantity % Market Cap. Importance
10/24/25
Truffle Capital SAS
BuyCompany 16,176 0.0411%
9/27/25
Truffle Capital SAS
BuyCompany 18,382 0.0467%
2/6/24
Truffle Capital SAS
BuyCompany 1,419,871 4.5955%
Change 5-day change 1-year change 3-year change Capi.($)
+0.36%-6.42%+286.06%+346.77% 364M
-0.45%+2.12%-18.93%+10.54% 178B
+0.86%+2.15%-19.13%+16.07% 116B
+0.88%+1.88%+1.66%+36.51% 115B
-2.26%+2.24%-44.03%+5.76% 93.1B
-0.31%-4.72%-3.36%+72.86% 62.09B
+0.04%+0.13%+10.73%+84.40% 55.87B
+0.07%+0.42%+5.94%-22.43% 53.12B
+0.30%+1.70%-11.26%+43.83% 44.22B
+0.10%+3.08%-3.06%-8.71% 33.59B
Average -0.04%+2.49%+20.46%+58.56% 75.14B
Weighted average by Cap. -0.12%+3.69%-12.36%+24.35%

Financials

2026 *2027 *
Net sales 1.43M 1.28M 1.19M 1.08M 2.01M 136M 2.03M 14.2M 5.66M 71.37M 5.37M 5.26M 227M 37.35M 33.51M 30.99M 28.06M 52.43M 3.56B 53.06M 370M 148M 1.86B 140M 137M 5.91B
Net income -37.59M -33.72M -31.18M -28.24M -52.76M -3.58B -53.39M -373M -148M -1.87B -141M -138M -5.95B -11.54M -10.35M -9.57M -8.67M -16.2M -1.1B -16.39M -114M -45.59M -575M -43.31M -42.39M -1.83B
Net Debt 35.01M 31.41M 29.04M 26.3M 49.14M 3.33B 49.74M 347M 138M 1.74B 131M 129M 5.54B 68.99M 61.89M 57.22M 51.83M 96.82M 6.57B 98M 684M 273M 3.44B 259M 253M 10.91B
Projected Income Statement - Annual - Carvolix
Logo Carvolix
Carvolix (formerly Affluent Medical) specializes in the development of AI-based mini-robots and biomimetic implants designed to autonomously replace heart valves and treat strokes.
Employees
102
Date Price Change Volume
26-10-28 €5.540 +0.36% 13,245
26-10-27 €5.520 -6.12% 40,218
26-10-26 €5.880 +1.73% 29,181
26-10-23 €5.780 -2.69% 6,634
26-10-22 €5.940 +0.34% 15,136
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Carvolix
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
5.540EUR
Average target price
8.775EUR
Spread / Average Target
+58.39%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Carvolix